CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Genus PLC (GNS) is a is a world-leading animal genetics business. Headquartered in Basingstoke, UK, it sells products produced using biotechnology to pig and cattle farmers. The business has manufacturing facilities in key locations around the world, paired with sales forces in 75 countries. The Genus share price is listed on the London Stock Exchange and included in the FTSE 250 Index.
The company’s beginnings date back to 1933 when the Milk Marketing Board’s Breeding and Production Division was founded in the UK. The key breakthrough in the Genus development happened in 1999 when the business acquired ABS Global, a US-based company founded by J.R. Prentice. As of 2018, the company’s annual revenue was £470.3 million.
Check the GNS share price at Capital.com.
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.